Diabetic macular edema: Review and update

Ophthalmology Clinics of North America

Volumn 15, Issue 4, 2002, Pages 555-563

  Pelzek, Christopher ^a   Lim, Jennifer I ^b  

^a Retina Vitreous Associates   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTISONE; DEXAMETHASONE; FLUOCINOLONE; INSULIN; RUBOXISTAURIN; STREPTOZOCIN;

AGE; CARDIOVASCULAR DISEASE; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE COURSE; ECONOMIC ASPECT; GENDER; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; INTRAOCULAR PRESSURE ABNORMALITY; MEDICAL SPECIALIST; NEUROLOGIC DISEASE; NONHUMAN; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RETINA MACULA EDEMA; REVIEW; SCREENING; SURVIVAL RATE; SYSTEMIC THERAPY; VISUAL ACUITY; VISUAL IMPAIRMENT;

DIABETIC RETINOPATHY; HUMANS; MACULAR EDEMA, CYSTOID; VISION DISORDERS;

EID: 0036937105     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-1549(02)00043-3     Document Type: Review

References (85)

1. Klein R. Diabetic retinopathy. Annu Rev Public Health 1996;17:137-58.
2. OPCS. Causes of Blindness and Partial Sight in England and Wales, 1990-1991. London HMSO, 1995.
3. Kohner EM, Porta M. Protocols for screening and treatment of diabetic retinopathy in Europe. Eur J Ophthalmol 1991;1:45-54.
4. Aiello LM, Cavallerano JD, Aiello LP, et al. Diabetic retinopathy. In: Guyer DR, Yannuzzi LA, Chang S, et al, editors. Retina-Vitreous-Macula. Vol 1. Philadelphia: WB Saunders; 1999. p. 316-44.
5. Ferris FL, Patz A. Macular edema: A complication of diabetic retinopathy. Surv Ophthalmol 1984;28: 452-61.
6. Moss SE, Klein R, Klein B. The 14-year incidence of visual loss in a diabetic population. Ophthalmology 1998; 105:998-1003.
7. Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, IV: Diabetic macular edema. Ophthalmology 1984;91:1464-74.
8. ETDRS Research Group. Photocoagulation for diabetic macular edema: ETDRS Report 1. Arch Ophthalmol 1985;103:1796-806.
9. Fine BS, Brucker AJ. Macular edema and cystoid macular edema. Am J Ophthalmol 1981;92:466-81.
10. Gass JDM, Anderson DR, Davis EB. A clinical, fluorescein angiographic, and electron microscopic correlation of cystoid macular edema. Am J Ophthalmol 1985;100:82-6.
11. Arend O, Remky A, Harris A, et al. Macular microcirculation in cystoid maculopathy of diabetic patients. Br J Opthalmol 1995;79:628-32.
12. Smith RT, Lee CM, Charles HC, et al. Quantification of diabetic macular edema. Arch Ophthalmol 1987; 105:218-22.
13. Ashton N. Studies of the retinal capillaries in relation to diabetic and other retinopathies. Br J Ophthalmol 1963;47:521-38.
14. Cogan DG, Toussaint D, Kuwabara T. Retinal vascular patterns. Arch Ophthalmol 1961;66:100-12.
15. Engerman RL, Kern TS. Progression of incipient diabetic retinopathy during good glycemic control. Diabetes 1987;36:808-12.
16. Kohner EM, Henkind P. Correlation of fluorescein angiogram and retinal digest in diabetic retinopathy. Am J Ophthalmol 1970;69:403-13.
17. de Venecia G, Davis M, Engerman R. Clinicopathologic correlations in diabetic retinopathy, I: Histology and fluorescein angiography of microaneurysms. Arch Ophthalmol 1976;94:1766-73.
18. Krupin T, Waltman SR, Szewczyk P, et al. Fluorometric studies on the blood-retinal barrier in experimental animals. Arch Ophthalmol 1982;100:631-4.
19. Gillies MC, Su T, Stayt J, et al. Effect of high glucose on permeability of retinal capillary endothelium in vitro. Invest Ophthalmol Vis Sci 1997;38:635-41.
20. Gardner TW, Lieth E, Khin SA, et al. Astrocytes increase barrier properties and ZO-I expression in retinal vascular endothelial cells. Invest Ophthalmol Vis Sci 1997;38:2423-7.
21. Wallow IHL, Engerman RL. Permeability and patency of retinal blood vessels in experimental diabetes. Invest Ophthalmol Vis Sci 1977;16:447-60.
22. Vinores SA, Niel EV, Swerdloff JL, et al. Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats. Exp Eye Res 1993;57:723-35.
23. Vitale S, Maguire MG, Murphy RP, et al. Clinically significant macular edema in type I diabetes: Incidence and risk factors. Ophthalmology 1995;102:1170-6.
24. DCCT Research Group. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Ophthalmology 1995;102:647-61.
25. Roy MS, Klein R. Macular edema and retinal hard exudates in African-Americans with type I diabetes: The New Jersey 725. Arch Ophthalmol 2001;119: 251-9.
26. Lopes de Faria JM, Jalkh AE, Trempe CL, et al. Diabetic macular edema: Risk factors and concomitants. Acta Ophthalmol Scand 1999;77:170-5.
27. Klein BE, Moss SE, Klein R, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, XIII: Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology 1991;98:1261-5.
28. Chew EY, Klein ML, Ferris FL, et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy: ETDRS Report 22. Arch Ophthalmol 1996;114:1079-84.
29. Sinclair SH, Nesler C, Foxman B, et al. Macular edema and pregnancy in insulin-dependent diabetes. Am J Ophthalmol 1984;97:154-67.
30. Best RM, Chakravarthy U. Diabetic retinopathy in pregnancy. Br J Ophthalmol 1997;81:249-51.
31. Sunness JS. The pregnant woman's eye. Surv Ophthalmol 1988;32:219-38.
32. Meyers SM. Macular edema after scatter laser photocoagulation for proliferative diabetic retinopathy. Am J Ophthalmol 1980;90:210-6.
33. McDonald HR, Schatz H. Macular edema following panretinal photocoagulation. Retina 1985;5:5-10.
34. Jaffe GJ, Burton TC, Kuhn E, et al. Progression of nonproliferative diabetic retinopathy and visual outcome after extracapsular cataract extraction and intraocular lens implantation. Am J Ophthalmol 1992;114: 448-56.
35. Dowler JGF, Sehmi KS, Hykin PG, et al. The natural history of macular edema after cataract surgery in diabetes. Ophthalmology 1999;106:663-8.
36. Kinyoun J, Barton F, Fisher M, et al. Detection of diabetic macular edema: Ophthalmoscopy versus photography: ETDRS Report 5. Ophthalmology 1989;96: 746-51.
37. Bresnick G. Diabetic maculopathy: A critical review highlighting diffuse macular edema. Ophthalmology 1983;90:1301-17.
38. Lewis H, Abrams GW, Blumenkranz MS, et al. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 1992;99:753-9.
39. Pendergast SD, Hassan TS, Williams GA, et al. Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid. Am J Ophthalmol 2000;130:178-86.
40. Nasrallah FP, Jalkh AE, Van Coppenolle F, et al. The role of the vitreous in diabetic macular edema. Ophthalmology 1988;95:1335-9.
41. Hikichi T, Fujio N, Akiba Y, et al. Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship. Ophthalmology 1997;104:473-8.
42. Schatz H, Patz A. Cystoid maculopathy in diabetics. Arch Ophthalmol 1976;94:761-8.
43. Kearns M, Hamilton AM, Kohner EM. Excessive permeability in diabetic maculopathy. Br J Opthalmol 1979;63:489-97.
44. ETDRS Research Group. Focal photocoagulation treatment of diabetic macular edema: Relationship of treatment effect to fluorescein angiography and other retinal characteristics at baseline: ETDRS Report 19. Arch Ophthalmol 1995;113:1144-55.
45. Lee CM, Olk RJ. Modified grid laser photocoagulation for diffuse diabetic macular edem?: Long-term visual results. Ophthalmology 1991;98:1594-602.
46. Townsend C, Bailey J, Kohner EM. Xenon arc photocoagulation in the treatment of diabetic maculopathy. Trans Ophthalmol Soc U K 1979;99:13-6.
47. Sigurdsson R, Begg IS. Organised macular plaques in exudative diabetic maculopathy. Br J Ophthalmol 1980;64:392-7.
48. Kohner EM, Dollery CT, Paterson JW, et al. Arterial fluorescein studies in diabetic retinopathy. Diabetes 1967; 16:1-10.
49. Bresnick GH, Condit R, Syrjala S, et al. Abnormalities of the foveal avascular zone in diabetic retinopathy. Arch Ophthalmol 1984;102:1286-93.
50. Abu El Asar AM, Morse PH. Laser photocoagulation control of diabetic macular edema without fluorescein angiography. Br J Ophthalmol 1991;75:97-9.
51. Hee MR, Puliafito CA, Wong C, et al. Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol 1995;113:1019-29.
52. Giovannini A, Amato G, Mariotti C, et al. Optical coherence tomography findings in diabetic macular edema before and after vitrectomy. Ophthalmic Surg Lasers 2000;31:187-91.
53. Otani T, Kishi S. Tomographic assessment of vitreous surgery for diabetic macular edema. Am J Ophthalmol 2000;129:487-94.
54. Hee MR, Puliafito CA, Duker JS, et al. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology 1998;105:360-70.
55. Asrani S, Zeimer R, Goldberg MF, et al. Application of rapid scanning retinal thickness analysis in retinal diseases. Ophthalmology 1997;104:1145-51.
56. Weinberger D, Axer-Siegel R, Landau D, et al. Retinal thickness variation in the diabetic patient measured by the retinal thickness analyzer. Br J Ophthalmol 1998;82:1003-6.
57. Shahidi M, Ogura Y, Blair NP, et al. Retinal thickness change after focal laser treatment of diabetic macular edema. Br J Ophthalmol 1994;78:827-30.
58. Tokuyama T, Ikeda T, Sato K. Effects of haemodialysis on diabetic macular leakage. Br J Ophthalmol 2000; 84:1397-400.
59. Ramsay RC, Knobloch WH, Barbosa JJ, et al. The visual status of diabetic patients after renal transplantation. Am J Ophthalmol 1979;87:305-10.
60. Ulbig M, Kampik A, Thurau S, et al. Long-term follow-up of diabetic retinopathy for up to 71 months after combined renal and pancreatic transplantation. Graefes Arch Clin Exp Ophthalmol 1991;229:242-5.
61. Patz A, Schatz H, Berkow JW, et al. Macular edema an overlooked complication of diabetic retinopathy. Trans Am Acad Ophthalmol Otolaryngol 1973;77: OP34-42.
62. Multicenter Controlled Study. Photocoagulation in treatment of diabetic maculopathy. Lancet 1975; 2:1110-3.
63. Blankenship GW. Diabetic macular edema and argon laser photocoagulation: A prospective randomized study. Ophthalmology 1979;86:69-78.
64. Olk RJ. Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema. Ophthalmology 1986;93:938-48.
65. Varley MP, Frank E, Purnell EW. Subretinal neovascularization after focal argon laser for diabetic macular edema. Ophthalmology 1988;95:567-73.
66. Lewis H, Schachat AP, Haimann M, et al. Choroidal neovascularization after laser photocoagulation for diabetic macular edema. Ophthalmology 1990;97:503-11.
67. Han DP, Mieler WF, Burton TC. Submacular fibrosis after photocoagulation for diabetic macular edema. Am J Ophthalmol 1992; 113:513-21.
68. Rutledge BK, Wallow IHL, Poulsen GL. Sub-pigment epithelial membranes after photocoagulation for diabetic macular edema. Arch Ophthalmol 1993;111: 608-13.
69. Schatz H, Madeira D, McDonald HR, et al. Progressiv enlargement of laser scars following grid laser photocoagulation for diffuse macular edema. Arch Ophthalmol 1991;109:1549-51.
70. Kaiser P, Riemann C, Sears J, et al. Macular traction detachment and diabetic macular edema associated with posterior hyaloidal traction. Am J Ophthalmol 2001;131:44-9.
71. Van Effenterre G, Guyot-Argenton C, Guiberteau B, et al. Macular edema caused by contraction of the posterior hyaloid in diabetic retinopathy: Surgical treatment of 22 cases [in French]. J Fr Ophtalmol 1993; 16:602-10.
72. Tachi N, Ogino N. Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 1 1996;122:258-60.
73. Gandorfer A, Messmer EM, Ulbig MW, et al. Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 2000;20:126-33.
74. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480-7.
75. Aiello LP, Wong JS. Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int 2000;77:S113-9.
76. Aiello LP, Bursell SE, Clermont A, et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 1997;46:1473-80.
77. Ishii H, Jirousek MR, Koya D, et al. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 1996;272:728-31.
78. Nauck M, Karakiulakis G, Perruchoud AP, et al. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol 1998;341:309-15.
79. Heiss JD, Papvassiliou E, Merrill M, et al. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. J Clin Invest 1996; 98:1400-8.
80. Jonas JB, Sofker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 2001;132:425-7.
81. Jaffe GJ, Yang CH, Guo H, et al. Safety and pharmokinetics of an intraocular fluocinolone acetonide sustained delivery device. Invest Ophthalmol Vis Sci 2000;41:3569-75.
82. Pearson PA, Abou Jaoude E, Smith TJ, et al. A phase I evaluation of sustained delivery fluocinolone in the treatment of diabetic macular edema. AAO Annual Meeting Programy, 2000, p 99.
83. Klein R, Klein BE, Moss SE, et al. Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol 1999;117:1487-95.
84. Klein R. Diabetic retinopathy: An end of the century perspective. Eye 1999;13:133-5.
85. The National Eye Health Education Program. From vision research to eye health education: planning the partnership. Bethesda, MD: National Institutes of Health, 1990.